SomaLogic, Inc.
SomaLogic, Inc. SLGC Peers
See (SLGC) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SLGC | $2.10 | -8.30% | 396.2M | -3.04 | -$0.69 | N/A |
| VEEV | $281.19 | +0.60% | 46B | 59.84 | $4.70 | N/A |
| GEHC | $74.86 | +2.91% | 34.3B | 15.73 | $4.76 | +0.17% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | +0.17% |
| DOCS | $60.41 | +0.40% | 11.3B | 54.42 | $1.11 | N/A |
| HQY | $104.86 | +0.86% | 9.1B | 76.54 | $1.37 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| BTSG | $23.08 | +2.08% | 4.1B | 85.48 | $0.27 | N/A |
| BTSGU | $80.39 | +1.48% | 3.9B | N/A | N/A | N/A |
Stock Comparison
SLGC vs VEEV Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, VEEV has a market cap of 46B. Regarding current trading prices, SLGC is priced at $2.10, while VEEV trades at $281.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas VEEV's P/E ratio is 59.84. In terms of profitability, SLGC's ROE is -0.19%, compared to VEEV's ROE of +0.14%. Regarding short-term risk, SLGC is more volatile compared to VEEV. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs GEHC Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, GEHC has a market cap of 34.3B. Regarding current trading prices, SLGC is priced at $2.10, while GEHC trades at $74.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas GEHC's P/E ratio is 15.73. In terms of profitability, SLGC's ROE is -0.19%, compared to GEHC's ROE of +0.26%. Regarding short-term risk, SLGC is more volatile compared to GEHC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs GEHCV Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, SLGC is priced at $2.10, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas GEHCV's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to GEHCV's ROE of +0.26%. Regarding short-term risk, SLGC is more volatile compared to GEHCV. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs DOCS Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, DOCS has a market cap of 11.3B. Regarding current trading prices, SLGC is priced at $2.10, while DOCS trades at $60.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas DOCS's P/E ratio is 54.42. In terms of profitability, SLGC's ROE is -0.19%, compared to DOCS's ROE of +0.22%. Regarding short-term risk, SLGC is more volatile compared to DOCS. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs HQY Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HQY has a market cap of 9.1B. Regarding current trading prices, SLGC is priced at $2.10, while HQY trades at $104.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HQY's P/E ratio is 76.54. In terms of profitability, SLGC's ROE is -0.19%, compared to HQY's ROE of +0.06%. Regarding short-term risk, SLGC is more volatile compared to HQY. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SGFY Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, SLGC is priced at $2.10, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SGFY's P/E ratio is 70.91. In terms of profitability, SLGC's ROE is -0.19%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, SLGC is more volatile compared to SGFY. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs RCM Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, SLGC is priced at $2.10, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas RCM's P/E ratio is -102.21. In terms of profitability, SLGC's ROE is -0.19%, compared to RCM's ROE of -0.02%. Regarding short-term risk, SLGC is more volatile compared to RCM. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs BTSG Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BTSG has a market cap of 4.1B. Regarding current trading prices, SLGC is priced at $2.10, while BTSG trades at $23.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BTSG's P/E ratio is 85.48. In terms of profitability, SLGC's ROE is -0.19%, compared to BTSG's ROE of +0.03%. Regarding short-term risk, SLGC is more volatile compared to BTSG. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs BTSGU Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BTSGU has a market cap of 3.9B. Regarding current trading prices, SLGC is priced at $2.10, while BTSGU trades at $80.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BTSGU's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to BTSGU's ROE of +0.03%. Regarding short-term risk, SLGC is more volatile compared to BTSGU. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs ONEM Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, SLGC is priced at $2.10, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ONEM's P/E ratio is -7.77. In terms of profitability, SLGC's ROE is -0.19%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, SLGC is more volatile compared to ONEM. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs PRVA Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, SLGC is priced at $2.10, while PRVA trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PRVA's P/E ratio is 183.33. In terms of profitability, SLGC's ROE is -0.19%, compared to PRVA's ROE of +0.02%. Regarding short-term risk, SLGC is more volatile compared to PRVA. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs WGS Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, WGS has a market cap of 2.6B. Regarding current trading prices, SLGC is priced at $2.10, while WGS trades at $89.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas WGS's P/E ratio is -64.45. In terms of profitability, SLGC's ROE is -0.19%, compared to WGS's ROE of -0.17%. Regarding short-term risk, SLGC is more volatile compared to WGS. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs CERT Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CERT has a market cap of 1.9B. Regarding current trading prices, SLGC is priced at $2.10, while CERT trades at $11.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CERT's P/E ratio is -571.00. In terms of profitability, SLGC's ROE is -0.19%, compared to CERT's ROE of -0.00%. Regarding short-term risk, SLGC is more volatile compared to CERT. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs PGNY Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PGNY has a market cap of 1.8B. Regarding current trading prices, SLGC is priced at $2.10, while PGNY trades at $21.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PGNY's P/E ratio is 37.65. In terms of profitability, SLGC's ROE is -0.19%, compared to PGNY's ROE of +0.12%. Regarding short-term risk, SLGC is more volatile compared to PGNY. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs PINC Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PINC has a market cap of 1.8B. Regarding current trading prices, SLGC is priced at $2.10, while PINC trades at $21.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PINC's P/E ratio is 21.39. In terms of profitability, SLGC's ROE is -0.19%, compared to PINC's ROE of +0.03%. Regarding short-term risk, SLGC is more volatile compared to PINC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs GDRX Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, GDRX has a market cap of 1.8B. Regarding current trading prices, SLGC is priced at $2.10, while GDRX trades at $4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas GDRX's P/E ratio is 70.43. In terms of profitability, SLGC's ROE is -0.19%, compared to GDRX's ROE of +0.07%. Regarding short-term risk, SLGC is more volatile compared to GDRX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs PHR Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PHR has a market cap of 1.7B. Regarding current trading prices, SLGC is priced at $2.10, while PHR trades at $27.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PHR's P/E ratio is -37.74. In terms of profitability, SLGC's ROE is -0.19%, compared to PHR's ROE of -0.16%. Regarding short-term risk, SLGC is more volatile compared to PHR. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs NXGN Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, SLGC is priced at $2.10, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas NXGN's P/E ratio is -266.00. In terms of profitability, SLGC's ROE is -0.19%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, SLGC is more volatile compared to NXGN. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SDGR Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SDGR has a market cap of 1.5B. Regarding current trading prices, SLGC is priced at $2.10, while SDGR trades at $20.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SDGR's P/E ratio is -7.79. In terms of profitability, SLGC's ROE is -0.19%, compared to SDGR's ROE of -0.45%. Regarding short-term risk, SLGC is more volatile compared to SDGR. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs TXG Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, TXG has a market cap of 1.5B. Regarding current trading prices, SLGC is priced at $2.10, while TXG trades at $11.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas TXG's P/E ratio is -9.00. In terms of profitability, SLGC's ROE is -0.19%, compared to TXG's ROE of -0.22%. Regarding short-term risk, SLGC is more volatile compared to TXG. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs TDOC Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, TDOC has a market cap of 1.4B. Regarding current trading prices, SLGC is priced at $2.10, while TDOC trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas TDOC's P/E ratio is -1.36. In terms of profitability, SLGC's ROE is -0.19%, compared to TDOC's ROE of -0.68%. Regarding short-term risk, SLGC is more volatile compared to TDOC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs AGTI Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, SLGC is priced at $2.10, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas AGTI's P/E ratio is -71.79. In terms of profitability, SLGC's ROE is -0.19%, compared to AGTI's ROE of -0.01%. Regarding short-term risk, SLGC is more volatile compared to AGTI. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs OMCL Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, OMCL has a market cap of 1.4B. Regarding current trading prices, SLGC is priced at $2.10, while OMCL trades at $28.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas OMCL's P/E ratio is 62.71. In terms of profitability, SLGC's ROE is -0.19%, compared to OMCL's ROE of +0.02%. Regarding short-term risk, SLGC is more volatile compared to OMCL. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs EVH Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, EVH has a market cap of 1.3B. Regarding current trading prices, SLGC is priced at $2.10, while EVH trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas EVH's P/E ratio is -8.83. In terms of profitability, SLGC's ROE is -0.19%, compared to EVH's ROE of -0.11%. Regarding short-term risk, SLGC is more volatile compared to EVH. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs HSTM Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HSTM has a market cap of 833M. Regarding current trading prices, SLGC is priced at $2.10, while HSTM trades at $27.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HSTM's P/E ratio is 43.32. In terms of profitability, SLGC's ROE is -0.19%, compared to HSTM's ROE of +0.05%. Regarding short-term risk, SLGC is more volatile compared to HSTM. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs CTEV Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CTEV has a market cap of 709.3M. Regarding current trading prices, SLGC is priced at $2.10, while CTEV trades at $42.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CTEV's P/E ratio is -0.59. In terms of profitability, SLGC's ROE is -0.19%, compared to CTEV's ROE of -5.18%. Regarding short-term risk, SLGC is more volatile compared to CTEV. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs NUTX Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, NUTX has a market cap of 658.1M. Regarding current trading prices, SLGC is priced at $2.10, while NUTX trades at $118.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas NUTX's P/E ratio is 9.59. In terms of profitability, SLGC's ROE is -0.19%, compared to NUTX's ROE of +0.71%. Regarding short-term risk, SLGC is more volatile compared to NUTX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs MPLN-WT Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, SLGC is priced at $2.10, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MPLN-WT's ROE of -5.18%. Regarding short-term risk, SLGC is less volatile compared to MPLN-WT. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs ACCD Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, SLGC is priced at $2.10, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ACCD's P/E ratio is -3.08. In terms of profitability, SLGC's ROE is -0.19%, compared to ACCD's ROE of -0.45%. Regarding short-term risk, SLGC is more volatile compared to ACCD. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SHCR Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, SLGC is priced at $2.10, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SHCR's P/E ratio is -3.76. In terms of profitability, SLGC's ROE is -0.19%, compared to SHCR's ROE of -0.24%. Regarding short-term risk, SLGC is more volatile compared to SHCR. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs DH Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, DH has a market cap of 406.8M. Regarding current trading prices, SLGC is priced at $2.10, while DH trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas DH's P/E ratio is -0.86. In terms of profitability, SLGC's ROE is -0.19%, compared to DH's ROE of -1.07%. Regarding short-term risk, SLGC is more volatile compared to DH. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SLGCW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, SLGC is priced at $2.10, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, SLGC's ROE is -0.19%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, SLGC is less volatile compared to SLGCW. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs MPLN Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, SLGC is priced at $2.10, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MPLN's P/E ratio is -0.23. In terms of profitability, SLGC's ROE is -0.19%, compared to MPLN's ROE of -5.18%. Regarding short-term risk, SLGC is more volatile compared to MPLN. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs NRC Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, NRC has a market cap of 368.6M. Regarding current trading prices, SLGC is priced at $2.10, while NRC trades at $16.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas NRC's P/E ratio is 15.86. In terms of profitability, SLGC's ROE is -0.19%, compared to NRC's ROE of +0.71%. Regarding short-term risk, SLGC is more volatile compared to NRC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SPOK Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SPOK has a market cap of 357.1M. Regarding current trading prices, SLGC is priced at $2.10, while SPOK trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SPOK's P/E ratio is 22.55. In terms of profitability, SLGC's ROE is -0.19%, compared to SPOK's ROE of +0.10%. Regarding short-term risk, SLGC is more volatile compared to SPOK. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs TBRG Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, TBRG has a market cap of 354.9M. Regarding current trading prices, SLGC is priced at $2.10, while TBRG trades at $23.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas TBRG's P/E ratio is -19.36. In terms of profitability, SLGC's ROE is -0.19%, compared to TBRG's ROE of -0.10%. Regarding short-term risk, SLGC is more volatile compared to TBRG. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SLP Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SLP has a market cap of 344.3M. Regarding current trading prices, SLGC is priced at $2.10, while SLP trades at $17.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SLP's P/E ratio is 47.56. In terms of profitability, SLGC's ROE is -0.19%, compared to SLP's ROE of +0.04%. Regarding short-term risk, SLGC is more volatile compared to SLP. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs TRHC Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, SLGC is priced at $2.10, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas TRHC's P/E ratio is -4.27. In terms of profitability, SLGC's ROE is -0.19%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, SLGC is more volatile compared to TRHC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SY Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SY has a market cap of 269M. Regarding current trading prices, SLGC is priced at $2.10, while SY trades at $2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SY's P/E ratio is -2.55. In terms of profitability, SLGC's ROE is -0.19%, compared to SY's ROE of -0.28%. Regarding short-term risk, SLGC is more volatile compared to SY. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs HCAT Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HCAT has a market cap of 260.7M. Regarding current trading prices, SLGC is priced at $2.10, while HCAT trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HCAT's P/E ratio is -3.26. In terms of profitability, SLGC's ROE is -0.19%, compared to HCAT's ROE of -0.20%. Regarding short-term risk, SLGC is more volatile compared to HCAT. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SMFR Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, SLGC is priced at $2.10, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SMFR's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to SMFR's ROE of -0.17%. Regarding short-term risk, SLGC is less volatile compared to SMFR. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs OPRX Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, OPRX has a market cap of 234M. Regarding current trading prices, SLGC is priced at $2.10, while OPRX trades at $12.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas OPRX's P/E ratio is -15.06. In terms of profitability, SLGC's ROE is -0.19%, compared to OPRX's ROE of -0.13%. Regarding short-term risk, SLGC is more volatile compared to OPRX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SOPH Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SOPH has a market cap of 207.2M. Regarding current trading prices, SLGC is priced at $2.10, while SOPH trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SOPH's P/E ratio is -3.10. In terms of profitability, SLGC's ROE is -0.19%, compared to SOPH's ROE of -0.63%. Regarding short-term risk, SLGC is more volatile compared to SOPH. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs EUDA Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, EUDA has a market cap of 133.8M. Regarding current trading prices, SLGC is priced at $2.10, while EUDA trades at $3.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas EUDA's P/E ratio is -6.67. In terms of profitability, SLGC's ROE is -0.19%, compared to EUDA's ROE of +3.05%. Regarding short-term risk, SLGC is more volatile compared to EUDA. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs CPSI Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, SLGC is priced at $2.10, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CPSI's P/E ratio is -183.80. In terms of profitability, SLGC's ROE is -0.19%, compared to CPSI's ROE of -0.18%. Regarding short-term risk, SLGC is more volatile compared to CPSI. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs AMWL Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, AMWL has a market cap of 120.9M. Regarding current trading prices, SLGC is priced at $2.10, while AMWL trades at $7.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas AMWL's P/E ratio is -0.76. In terms of profitability, SLGC's ROE is -0.19%, compared to AMWL's ROE of -0.48%. Regarding short-term risk, SLGC is more volatile compared to AMWL. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs AUGX Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, SLGC is priced at $2.10, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas AUGX's P/E ratio is -4.99. In terms of profitability, SLGC's ROE is -0.19%, compared to AUGX's ROE of -1.13%. Regarding short-term risk, SLGC is more volatile compared to AUGX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs CCLDO Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CCLDO has a market cap of 109.7M. Regarding current trading prices, SLGC is priced at $2.10, while CCLDO trades at $19.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CCLDO's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to CCLDO's ROE of +0.21%. Regarding short-term risk, SLGC is more volatile compared to CCLDO. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs CCLD Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CCLD has a market cap of 96.5M. Regarding current trading prices, SLGC is priced at $2.10, while CCLD trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CCLD's P/E ratio is -10.36. In terms of profitability, SLGC's ROE is -0.19%, compared to CCLD's ROE of +0.21%. Regarding short-term risk, SLGC is more volatile compared to CCLD. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs FORA Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, FORA has a market cap of 64.9M. Regarding current trading prices, SLGC is priced at $2.10, while FORA trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas FORA's P/E ratio is -17.33. In terms of profitability, SLGC's ROE is -0.19%, compared to FORA's ROE of -0.13%. Regarding short-term risk, SLGC is more volatile compared to FORA. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs CCLDP Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, SLGC is priced at $2.10, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CCLDP's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to CCLDP's ROE of +0.21%. Regarding short-term risk, SLGC is more volatile compared to CCLDP. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs BEAT Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BEAT has a market cap of 47.3M. Regarding current trading prices, SLGC is priced at $2.10, while BEAT trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BEAT's P/E ratio is -1.89. In terms of profitability, SLGC's ROE is -0.19%, compared to BEAT's ROE of -3.58%. Regarding short-term risk, SLGC is more volatile compared to BEAT. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs BEATW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BEATW has a market cap of 40.3M. Regarding current trading prices, SLGC is priced at $2.10, while BEATW trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BEATW's P/E ratio is -0.61. In terms of profitability, SLGC's ROE is -0.19%, compared to BEATW's ROE of -3.58%. Regarding short-term risk, SLGC is more volatile compared to BEATW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SNCE Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, SLGC is priced at $2.10, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SNCE's P/E ratio is -0.27. In terms of profitability, SLGC's ROE is -0.19%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, SLGC is more volatile compared to SNCE. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs AKLI Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, SLGC is priced at $2.10, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas AKLI's P/E ratio is -0.71. In terms of profitability, SLGC's ROE is -0.19%, compared to AKLI's ROE of -0.38%. Regarding short-term risk, SLGC is more volatile compared to AKLI. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SHLT Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, SLGC is priced at $2.10, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SHLT's P/E ratio is -3.87. In terms of profitability, SLGC's ROE is -0.19%, compared to SHLT's ROE of -0.09%. Regarding short-term risk, SLGC is more volatile compared to SHLT. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SHCRW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, SLGC is priced at $2.10, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, SLGC's ROE is -0.19%, compared to SHCRW's ROE of -0.24%. Regarding short-term risk, SLGC is more volatile compared to SHCRW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs RNLX Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, SLGC is priced at $2.10, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas RNLX's P/E ratio is -0.33. In terms of profitability, SLGC's ROE is -0.19%, compared to RNLX's ROE of +2.93%. Regarding short-term risk, SLGC is more volatile compared to RNLX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs STRM Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, STRM has a market cap of 22.5M. Regarding current trading prices, SLGC is priced at $2.10, while STRM trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas STRM's P/E ratio is -2.33. In terms of profitability, SLGC's ROE is -0.19%, compared to STRM's ROE of -0.68%. Regarding short-term risk, SLGC is more volatile compared to STRM. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs LIFW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, SLGC is priced at $2.10, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas LIFW's P/E ratio is -0.02. In terms of profitability, SLGC's ROE is -0.19%, compared to LIFW's ROE of -3.08%. Regarding short-term risk, SLGC is more volatile compared to LIFW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs VSEE Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, VSEE has a market cap of 17.9M. Regarding current trading prices, SLGC is priced at $2.10, while VSEE trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas VSEE's P/E ratio is -14.25. In terms of profitability, SLGC's ROE is -0.19%, compared to VSEE's ROE of -6.10%. Regarding short-term risk, SLGC is more volatile compared to VSEE. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs MGRX Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MGRX has a market cap of 17.8M. Regarding current trading prices, SLGC is priced at $2.10, while MGRX trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MGRX's P/E ratio is -0.39. In terms of profitability, SLGC's ROE is -0.19%, compared to MGRX's ROE of -0.73%. Regarding short-term risk, SLGC is more volatile compared to MGRX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs ONMD Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ONMD has a market cap of 16M. Regarding current trading prices, SLGC is priced at $2.10, while ONMD trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ONMD's P/E ratio is -1.54. In terms of profitability, SLGC's ROE is -0.19%, compared to ONMD's ROE of +0.60%. Regarding short-term risk, SLGC is more volatile compared to ONMD. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs BFRGW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BFRGW has a market cap of 14.9M. Regarding current trading prices, SLGC is priced at $2.10, while BFRGW trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BFRGW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to BFRGW's ROE of -1.33%. Regarding short-term risk, SLGC is more volatile compared to BFRGW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs BFRG Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BFRG has a market cap of 14.8M. Regarding current trading prices, SLGC is priced at $2.10, while BFRG trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BFRG's P/E ratio is -1.96. In terms of profitability, SLGC's ROE is -0.19%, compared to BFRG's ROE of -1.63%. Regarding short-term risk, SLGC is more volatile compared to BFRG. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs VSEEW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, VSEEW has a market cap of 14.4M. Regarding current trading prices, SLGC is priced at $2.10, while VSEEW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas VSEEW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to VSEEW's ROE of -6.10%. Regarding short-term risk, SLGC is more volatile compared to VSEEW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs BBLN Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, SLGC is priced at $2.10, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas BBLN's P/E ratio is -0.04. In terms of profitability, SLGC's ROE is -0.19%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, SLGC is more volatile compared to BBLN. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SCNX Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SCNX has a market cap of 12.8M. Regarding current trading prices, SLGC is priced at $2.10, while SCNX trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SCNX's P/E ratio is 1.58. In terms of profitability, SLGC's ROE is -0.19%, compared to SCNX's ROE of +0.19%. Regarding short-term risk, SLGC is more volatile compared to SCNX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs INOV Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, INOV has a market cap of 12.7M. Regarding current trading prices, SLGC is priced at $2.10, while INOV trades at $32.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas INOV's P/E ratio is 16.37. In terms of profitability, SLGC's ROE is -0.19%, compared to INOV's ROE of +0.03%. Regarding short-term risk, SLGC is more volatile compared to INOV. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs HCTI Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HCTI has a market cap of 10.8M. Regarding current trading prices, SLGC is priced at $2.10, while HCTI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HCTI's P/E ratio is -0.03. In terms of profitability, SLGC's ROE is -0.19%, compared to HCTI's ROE of -23.25%. Regarding short-term risk, SLGC is more volatile compared to HCTI. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs MSPR Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MSPR has a market cap of 10.3M. Regarding current trading prices, SLGC is priced at $2.10, while MSPR trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MSPR's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MSPR's ROE of -3.08%. Regarding short-term risk, SLGC is more volatile compared to MSPR. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs ETAO Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, SLGC is priced at $2.10, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ETAO's P/E ratio is -0.01. In terms of profitability, SLGC's ROE is -0.19%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, SLGC is less volatile compared to ETAO. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs HLTH Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, SLGC is priced at $2.10, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas HLTH's P/E ratio is -0.02. In terms of profitability, SLGC's ROE is -0.19%, compared to HLTH's ROE of -0.88%. Regarding short-term risk, SLGC is less volatile compared to HLTH. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs ZCMD Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ZCMD has a market cap of 6.3M. Regarding current trading prices, SLGC is priced at $2.10, while ZCMD trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ZCMD's P/E ratio is -10.08. In terms of profitability, SLGC's ROE is -0.19%, compared to ZCMD's ROE of -0.03%. Regarding short-term risk, SLGC is more volatile compared to ZCMD. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs UPH Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, SLGC is priced at $2.10, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas UPH's P/E ratio is -0.07. In terms of profitability, SLGC's ROE is -0.19%, compared to UPH's ROE of -1.05%. Regarding short-term risk, SLGC is less volatile compared to UPH. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs ACON Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ACON has a market cap of 4.1M. Regarding current trading prices, SLGC is priced at $2.10, while ACON trades at $7.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ACON's P/E ratio is -0.62. In terms of profitability, SLGC's ROE is -0.19%, compared to ACON's ROE of -1.27%. Regarding short-term risk, SLGC is more volatile compared to ACON. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs OTRK Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, OTRK has a market cap of 4.1M. Regarding current trading prices, SLGC is priced at $2.10, while OTRK trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas OTRK's P/E ratio is -0.06. In terms of profitability, SLGC's ROE is -0.19%, compared to OTRK's ROE of -2.70%. Regarding short-term risk, SLGC is more volatile compared to OTRK. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs PEAR Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, SLGC is priced at $2.10, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PEAR's P/E ratio is -0.08. In terms of profitability, SLGC's ROE is -0.19%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, SLGC is less volatile compared to PEAR. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs PEARW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, SLGC is priced at $2.10, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas PEARW's P/E ratio is -0.00. In terms of profitability, SLGC's ROE is -0.19%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, SLGC is less volatile compared to PEARW. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs EUDAW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, EUDAW has a market cap of 3.4M. Regarding current trading prices, SLGC is priced at $2.10, while EUDAW trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas EUDAW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to EUDAW's ROE of +3.05%. Regarding short-term risk, SLGC is more volatile compared to EUDAW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs WGSWW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, WGSWW has a market cap of 2.3M. Regarding current trading prices, SLGC is priced at $2.10, while WGSWW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas WGSWW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to WGSWW's ROE of -0.17%. Regarding short-term risk, SLGC is less volatile compared to WGSWW. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs FOXO Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, FOXO has a market cap of 2.1M. Regarding current trading prices, SLGC is priced at $2.10, while FOXO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas FOXO's P/E ratio is -0.03. In terms of profitability, SLGC's ROE is -0.19%, compared to FOXO's ROE of -0.01%. Regarding short-term risk, SLGC is more volatile compared to FOXO. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs CMAX Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, SLGC is priced at $2.10, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CMAX's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to CMAX's ROE of +30.94%. Regarding short-term risk, SLGC is less volatile compared to CMAX. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs WORX Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, WORX has a market cap of 1.5M. Regarding current trading prices, SLGC is priced at $2.10, while WORX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas WORX's P/E ratio is -0.47. In terms of profitability, SLGC's ROE is -0.19%, compared to WORX's ROE of -0.32%. Regarding short-term risk, SLGC is more volatile compared to WORX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs LIFWZ Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, SLGC is priced at $2.10, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to LIFWZ's ROE of -3.08%. Regarding short-term risk, SLGC is more volatile compared to LIFWZ. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs OTRKP Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, OTRKP has a market cap of 1M. Regarding current trading prices, SLGC is priced at $2.10, while OTRKP trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas OTRKP's P/E ratio is -0.08. In terms of profitability, SLGC's ROE is -0.19%, compared to OTRKP's ROE of -2.70%. Regarding short-term risk, SLGC is more volatile compared to OTRKP. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs ICCT Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ICCT has a market cap of 755.9K. Regarding current trading prices, SLGC is priced at $2.10, while ICCT trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ICCT's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to ICCT's ROE of +20.01%. Regarding short-term risk, SLGC is less volatile compared to ICCT. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs KERNW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, SLGC is priced at $2.10, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas KERNW's P/E ratio is -0.00. In terms of profitability, SLGC's ROE is -0.19%, compared to KERNW's ROE of -2.22%. Regarding short-term risk, SLGC is less volatile compared to KERNW. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs KERN Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, SLGC is priced at $2.10, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas KERN's P/E ratio is -0.01. In terms of profitability, SLGC's ROE is -0.19%, compared to KERN's ROE of -2.22%. Regarding short-term risk, SLGC is less volatile compared to KERN. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs MSPRZ Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MSPRZ has a market cap of 116.1K. Regarding current trading prices, SLGC is priced at $2.10, while MSPRZ trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MSPRZ's ROE of -3.08%. Regarding short-term risk, SLGC is more volatile compared to MSPRZ. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs LIFWW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, SLGC is priced at $2.10, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas LIFWW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to LIFWW's ROE of -3.08%. Regarding short-term risk, SLGC is more volatile compared to LIFWW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs CMAXW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, SLGC is priced at $2.10, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CMAXW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to CMAXW's ROE of +30.94%. Regarding short-term risk, SLGC is more volatile compared to CMAXW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs ACONW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, ACONW has a market cap of 19.6K. Regarding current trading prices, SLGC is priced at $2.10, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas ACONW's P/E ratio is -0.01. In terms of profitability, SLGC's ROE is -0.19%, compared to ACONW's ROE of -1.27%. Regarding short-term risk, SLGC is more volatile compared to ACONW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs MSPRW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MSPRW has a market cap of 7.7K. Regarding current trading prices, SLGC is priced at $2.10, while MSPRW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MSPRW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MSPRW's ROE of -3.08%. Regarding short-term risk, SLGC is more volatile compared to MSPRW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs UTRS Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, UTRS has a market cap of 888. Regarding current trading prices, SLGC is priced at $2.10, while UTRS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas UTRS's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to UTRS's ROE of -1.11%. Regarding short-term risk, SLGC is more volatile compared to UTRS. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs CHNG Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CHNG's P/E ratio is -152.72. In terms of profitability, SLGC's ROE is -0.19%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, SLGC is more volatile compared to CHNG. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs MTBC Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas MTBC's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to MTBC's ROE of +0.21%. Regarding short-term risk, SLGC is more volatile compared to MTBC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.
SLGC vs SMFRW Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas SMFRW's P/E ratio is N/A. In terms of profitability, SLGC's ROE is -0.19%, compared to SMFRW's ROE of -0.17%. Regarding short-term risk, SLGC is less volatile compared to SMFRW. This indicates potentially lower risk in terms of short-term price fluctuations for SLGC.
SLGC vs CNVY Comparison
SLGC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGC stands at 396.2M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, SLGC is priced at $2.10, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGC currently has a P/E ratio of -3.04, whereas CNVY's P/E ratio is -71.50. In terms of profitability, SLGC's ROE is -0.19%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, SLGC is more volatile compared to CNVY. This indicates potentially higher risk in terms of short-term price fluctuations for SLGC.